Cargando…
Lenvatinib plus pembrolizumab a new effective combination of targeted agents
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011194/ https://www.ncbi.nlm.nih.gov/pubmed/36863093 http://dx.doi.org/10.1016/j.esmoop.2023.101157 |
| _version_ | 1784906336426786816 |
|---|---|
| author | Perez-Fidalgo, J.A. Martinelli, E. |
| author_facet | Perez-Fidalgo, J.A. Martinelli, E. |
| author_sort | Perez-Fidalgo, J.A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10011194 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100111942023-03-15 Lenvatinib plus pembrolizumab a new effective combination of targeted agents Perez-Fidalgo, J.A. Martinelli, E. ESMO Open Editorial Elsevier 2023-02-28 /pmc/articles/PMC10011194/ /pubmed/36863093 http://dx.doi.org/10.1016/j.esmoop.2023.101157 Text en © 2023 Published by Elsevier Ltd on behalf of European Society for Medical Oncology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Perez-Fidalgo, J.A. Martinelli, E. Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title | Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title_full | Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title_fullStr | Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title_full_unstemmed | Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title_short | Lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| title_sort | lenvatinib plus pembrolizumab a new effective combination of targeted agents |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011194/ https://www.ncbi.nlm.nih.gov/pubmed/36863093 http://dx.doi.org/10.1016/j.esmoop.2023.101157 |
| work_keys_str_mv | AT perezfidalgoja lenvatinibpluspembrolizumabaneweffectivecombinationoftargetedagents AT martinellie lenvatinibpluspembrolizumabaneweffectivecombinationoftargetedagents |